MoneyWorks4Me

Panacea Biotec informs about disclosure of related party transactions

29 Nov 2022 Evaluate

Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular no. SEBIIHO/CFO/CMD1/CIRIP/2021/662 dated November 22, 2021, Panacea Biotec has informed that it enclosed disclosure of related party transactions for half year ended September 30, 2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..